Targeted Treatment and Immunotherapy in High-risk and Relapsed/Refractory Pediatric Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia is the most frequent pediatric malignancy in children, comprising 30% of all pediatric malignancies; adult ALL comprises 5% of all ALL cases, which have a 186.6 per 1 million incidence. In pediatric ALL (pALL), on which this review focuses, approximately 1 in 285 childre...

Descripción completa

Detalles Bibliográficos
Autores principales: Graiqevci-Uka, Violeta, Behluli, Emir, Spahiu, Lidvana, Liehr, Thomas, Temaj, Gazmend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009894/
https://www.ncbi.nlm.nih.gov/pubmed/36056858
http://dx.doi.org/10.2174/1573396318666220901165247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009894/
https://www.ncbi.nlm.nih.gov/pubmed/36056858
http://dx.doi.org/10.2174/1573396318666220901165247

Ejemplares similares